 Sylvie Kandel
Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytochrome P-450 Enzyme System | 9 | 2026 | 162 | 3.070 |
Why?
| | Cytochrome P-450 CYP3A | 8 | 2026 | 93 | 2.160 |
Why?
| | Pseudomonas aeruginosa | 3 | 2025 | 356 | 1.600 |
Why?
| | Cytochrome P-450 CYP3A Inhibitors | 3 | 2024 | 18 | 1.060 |
Why?
| | Celecoxib | 1 | 2025 | 41 | 0.920 |
Why?
| | Dehydroepiandrosterone Sulfate | 2 | 2023 | 42 | 0.870 |
Why?
| | Raloxifene Hydrochloride | 1 | 2024 | 15 | 0.850 |
Why?
| | Ciprofloxacin | 1 | 2024 | 26 | 0.840 |
Why?
| | Nevirapine | 1 | 2023 | 18 | 0.810 |
Why?
| | Deuterium | 1 | 2023 | 100 | 0.770 |
Why?
| | Quinolones | 1 | 2024 | 201 | 0.710 |
Why?
| | Aminophenols | 1 | 2024 | 201 | 0.700 |
Why?
| | Lopinavir | 1 | 2021 | 30 | 0.670 |
Why?
| | Ritonavir | 1 | 2021 | 75 | 0.650 |
Why?
| | Anti-Retroviral Agents | 1 | 2021 | 250 | 0.570 |
Why?
| | Cyclopentanes | 2 | 2007 | 20 | 0.490 |
Why?
| | Acetates | 2 | 2007 | 80 | 0.480 |
Why?
| | Cytochromes b5 | 1 | 2014 | 2 | 0.430 |
Why?
| | NADPH-Ferrihemoprotein Reductase | 1 | 2014 | 10 | 0.430 |
Why?
| | Chemical and Drug Induced Liver Injury | 3 | 2023 | 139 | 0.420 |
Why?
| | Testosterone | 1 | 2017 | 419 | 0.400 |
Why?
| | Pharmaceutical Preparations | 1 | 2014 | 170 | 0.370 |
Why?
| | Fluorocarbons | 2 | 2026 | 143 | 0.370 |
Why?
| | Hepatocytes | 2 | 2026 | 224 | 0.340 |
Why?
| | Arabidopsis Proteins | 2 | 2008 | 76 | 0.320 |
Why?
| | Arabidopsis | 2 | 2008 | 95 | 0.310 |
Why?
| | Oxylipins | 2 | 2007 | 47 | 0.310 |
Why?
| | Fatty Acids | 4 | 2022 | 452 | 0.300 |
Why?
| | Dicarboxylic Acids | 1 | 2007 | 11 | 0.270 |
Why?
| | Tretinoin | 2 | 2026 | 124 | 0.270 |
Why?
| | Naphthalenes | 2 | 2024 | 56 | 0.260 |
Why?
| | Retinoic Acid 4-Hydroxylase | 1 | 2026 | 3 | 0.240 |
Why?
| | Decanoic Acids | 1 | 2026 | 14 | 0.240 |
Why?
| | Teratogens | 1 | 2026 | 20 | 0.240 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 2025 | 23 | 0.230 |
Why?
| | Carboxylesterase | 1 | 2025 | 4 | 0.230 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2025 | 23 | 0.230 |
Why?
| | Molecular Docking Simulation | 3 | 2025 | 124 | 0.230 |
Why?
| | Molecular Structure | 3 | 2023 | 501 | 0.230 |
Why?
| | Acetaminophen | 2 | 2018 | 264 | 0.220 |
Why?
| | Liver | 4 | 2023 | 1888 | 0.220 |
Why?
| | Prodrugs | 1 | 2025 | 52 | 0.220 |
Why?
| | Clobetasol | 1 | 2024 | 7 | 0.220 |
Why?
| | Plant Proteins | 1 | 2005 | 112 | 0.220 |
Why?
| | Adenosine Monophosphate | 1 | 2025 | 86 | 0.220 |
Why?
| | Alanine | 1 | 2025 | 171 | 0.210 |
Why?
| | Antiviral Agents | 3 | 2025 | 768 | 0.210 |
Why?
| | HIV Reverse Transcriptase | 1 | 2023 | 31 | 0.200 |
Why?
| | Hydroxylation | 2 | 2017 | 49 | 0.200 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2023 | 87 | 0.200 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2026 | 276 | 0.190 |
Why?
| | Cystic Fibrosis | 2 | 2024 | 1158 | 0.190 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2025 | 338 | 0.190 |
Why?
| | Microsomes, Liver | 2 | 2024 | 85 | 0.180 |
Why?
| | Aloe | 1 | 2022 | 2 | 0.180 |
Why?
| | Kinetics | 3 | 2022 | 1629 | 0.180 |
Why?
| | Hydroxyeicosatetraenoic Acids | 1 | 2022 | 35 | 0.180 |
Why?
| | Fluoresceins | 1 | 2021 | 48 | 0.180 |
Why?
| | Heme | 2 | 2023 | 89 | 0.170 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2021 | 194 | 0.170 |
Why?
| | Molecular Conformation | 1 | 2021 | 148 | 0.160 |
Why?
| | Drug Combinations | 1 | 2021 | 392 | 0.150 |
Why?
| | Humans | 15 | 2026 | 144957 | 0.150 |
Why?
| | Glutathione | 2 | 2018 | 375 | 0.150 |
Why?
| | Iron | 2 | 2023 | 359 | 0.150 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 2017 | 598 | 0.150 |
Why?
| | Microsomes | 3 | 2008 | 33 | 0.140 |
Why?
| | Premature Birth | 1 | 2023 | 380 | 0.140 |
Why?
| | Biological Products | 1 | 2022 | 252 | 0.140 |
Why?
| | Acetylglucosamine | 1 | 2018 | 13 | 0.140 |
Why?
| | Animals | 6 | 2026 | 38109 | 0.140 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2018 | 24 | 0.140 |
Why?
| | Protective Agents | 1 | 2018 | 42 | 0.140 |
Why?
| | Berberis | 1 | 2017 | 1 | 0.130 |
Why?
| | Hydrastis | 1 | 2017 | 3 | 0.130 |
Why?
| | Berberine | 1 | 2017 | 5 | 0.130 |
Why?
| | Biotransformation | 1 | 2017 | 63 | 0.130 |
Why?
| | Bacterial Proteins | 1 | 2024 | 962 | 0.130 |
Why?
| | Stereoisomerism | 1 | 2017 | 105 | 0.130 |
Why?
| | Cloning, Molecular | 3 | 2008 | 541 | 0.130 |
Why?
| | Oxidation-Reduction | 1 | 2021 | 1087 | 0.130 |
Why?
| | Hypolipidemic Agents | 1 | 2017 | 88 | 0.130 |
Why?
| | Blotting, Northern | 2 | 2007 | 204 | 0.120 |
Why?
| | Anti-HIV Agents | 1 | 2023 | 888 | 0.120 |
Why?
| | Substrate Specificity | 2 | 2007 | 392 | 0.120 |
Why?
| | Plant Extracts | 1 | 2017 | 187 | 0.120 |
Why?
| | Sulfolobus acidocaldarius | 1 | 2015 | 4 | 0.110 |
Why?
| | HIV-1 | 1 | 2021 | 896 | 0.110 |
Why?
| | Archaeal Proteins | 1 | 2015 | 49 | 0.110 |
Why?
| | Protein Binding | 2 | 2018 | 2276 | 0.110 |
Why?
| | Serum Albumin | 1 | 2014 | 147 | 0.100 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 148 | 0.100 |
Why?
| | Infant, Newborn | 2 | 2026 | 6434 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2024 | 1915 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2017 | 576 | 0.100 |
Why?
| | Protein Isoforms | 1 | 2014 | 402 | 0.100 |
Why?
| | Fetus | 1 | 2017 | 803 | 0.090 |
Why?
| | Signal Transduction | 1 | 2026 | 5233 | 0.090 |
Why?
| | Receptors, Progesterone | 1 | 2014 | 356 | 0.090 |
Why?
| | Models, Molecular | 1 | 2015 | 1619 | 0.080 |
Why?
| | Hydrolysis | 2 | 2025 | 199 | 0.070 |
Why?
| | Epoxy Compounds | 1 | 2008 | 32 | 0.070 |
Why?
| | Biocatalysis | 1 | 2008 | 69 | 0.070 |
Why?
| | Hypoglycemic Agents | 1 | 2017 | 1389 | 0.070 |
Why?
| | Male | 4 | 2025 | 72406 | 0.060 |
Why?
| | Catalysis | 1 | 2007 | 322 | 0.060 |
Why?
| | DNA Primers | 1 | 2007 | 512 | 0.060 |
Why?
| | Biomarkers | 1 | 2017 | 4275 | 0.060 |
Why?
| | Hydroxylamines | 1 | 2025 | 8 | 0.060 |
Why?
| | Cytidine | 1 | 2025 | 9 | 0.060 |
Why?
| | Chromatography, Thin Layer | 1 | 2005 | 27 | 0.060 |
Why?
| | Stearic Acids | 1 | 2005 | 16 | 0.060 |
Why?
| | Phenobarbital | 1 | 2005 | 20 | 0.060 |
Why?
| | Triticum | 1 | 2005 | 17 | 0.060 |
Why?
| | Lauric Acids | 1 | 2005 | 9 | 0.060 |
Why?
| | Genome, Plant | 1 | 2005 | 34 | 0.060 |
Why?
| | HIV Infections | 1 | 2021 | 3154 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 983 | 0.060 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2005 | 131 | 0.060 |
Why?
| | Gene Library | 1 | 2005 | 126 | 0.060 |
Why?
| | DNA, Complementary | 1 | 2005 | 277 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2026 | 4155 | 0.050 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 2024 | 45 | 0.050 |
Why?
| | Models, Chemical | 1 | 2005 | 269 | 0.050 |
Why?
| | Base Sequence | 1 | 2007 | 2191 | 0.050 |
Why?
| | Dehydroepiandrosterone | 1 | 2023 | 50 | 0.050 |
Why?
| | Arachidonic Acid | 1 | 2022 | 101 | 0.040 |
Why?
| | Protease Inhibitors | 1 | 2022 | 102 | 0.040 |
Why?
| | Pregnancy | 2 | 2026 | 7191 | 0.040 |
Why?
| | Adult | 2 | 2023 | 40506 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2032 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2022 | 331 | 0.040 |
Why?
| | Pseudomonas Infections | 1 | 2022 | 221 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2021 | 330 | 0.040 |
Why?
| | High-Throughput Screening Assays | 1 | 2021 | 175 | 0.040 |
Why?
| | Birth Weight | 1 | 2023 | 522 | 0.040 |
Why?
| | Water | 1 | 2023 | 469 | 0.040 |
Why?
| | Acylation | 1 | 2018 | 30 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2026 | 2050 | 0.030 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2018 | 153 | 0.030 |
Why?
| | Pharmacopoeias as Topic | 1 | 2017 | 2 | 0.030 |
Why?
| | Food Inspection | 1 | 2017 | 2 | 0.030 |
Why?
| | Food Quality | 1 | 2017 | 11 | 0.030 |
Why?
| | Food Labeling | 1 | 2017 | 13 | 0.030 |
Why?
| | Capsules | 1 | 2017 | 43 | 0.030 |
Why?
| | Gene Expression | 2 | 2015 | 1490 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 5997 | 0.030 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2017 | 179 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2017 | 220 | 0.030 |
Why?
| | Peptide Mapping | 1 | 2015 | 63 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2015 | 224 | 0.030 |
Why?
| | Protein Stability | 1 | 2015 | 178 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 7183 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 577 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2015 | 234 | 0.030 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 369 | 0.030 |
Why?
| | Imidazoles | 1 | 2015 | 254 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2015 | 493 | 0.020 |
Why?
| | Pandemics | 1 | 2022 | 1695 | 0.020 |
Why?
| | Ligands | 1 | 2015 | 674 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2015 | 346 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 862 | 0.020 |
Why?
| | Internet | 1 | 2017 | 700 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1371 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 826 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2018 | 3125 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2931 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7997 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3415 | 0.020 |
Why?
| | Cytosol | 1 | 2008 | 227 | 0.020 |
Why?
| | Female | 2 | 2026 | 78376 | 0.010 |
Why?
| | United States | 1 | 2017 | 15988 | 0.010 |
Why?
|
|
Kandel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|